Cargando…
Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930022/ http://dx.doi.org/10.1016/S2666-6367(22)00643-1 |
| _version_ | 1784670971410513920 |
|---|---|
| author | Graham, Rudi-Ann Tamara Qayed, Muna Leung, Kathryn S Haight, Ann E Parikh, Suhag Watkins, Ben K. Horwitz, Edwin Chandrakasan, Shanmuganathan Schoettler, Michelle Long Bernardo, Valeria Harris, Anora Landry, Kelly Yee, Marianne Williams, Kirsten M. |
| author_facet | Graham, Rudi-Ann Tamara Qayed, Muna Leung, Kathryn S Haight, Ann E Parikh, Suhag Watkins, Ben K. Horwitz, Edwin Chandrakasan, Shanmuganathan Schoettler, Michelle Long Bernardo, Valeria Harris, Anora Landry, Kelly Yee, Marianne Williams, Kirsten M. |
| author_sort | Graham, Rudi-Ann Tamara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8930022 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89300222022-03-18 Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease Graham, Rudi-Ann Tamara Qayed, Muna Leung, Kathryn S Haight, Ann E Parikh, Suhag Watkins, Ben K. Horwitz, Edwin Chandrakasan, Shanmuganathan Schoettler, Michelle Long Bernardo, Valeria Harris, Anora Landry, Kelly Yee, Marianne Williams, Kirsten M. Transplant Cell Ther Poster Session - Infectious Diseases and Cytotoxic T Lymphocytes American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022-03 2022-03-18 /pmc/articles/PMC8930022/ http://dx.doi.org/10.1016/S2666-6367(22)00643-1 Text en Copyright © 2022 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Session - Infectious Diseases and Cytotoxic T Lymphocytes Graham, Rudi-Ann Tamara Qayed, Muna Leung, Kathryn S Haight, Ann E Parikh, Suhag Watkins, Ben K. Horwitz, Edwin Chandrakasan, Shanmuganathan Schoettler, Michelle Long Bernardo, Valeria Harris, Anora Landry, Kelly Yee, Marianne Williams, Kirsten M. Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease |
| title | Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease |
| title_full | Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease |
| title_fullStr | Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease |
| title_full_unstemmed | Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease |
| title_short | Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease |
| title_sort | favorable outcomes of pediatric hematopoietic cell transplant patients receiving regen-cov2 for prophylaxis against severe covid-19 disease |
| topic | Poster Session - Infectious Diseases and Cytotoxic T Lymphocytes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930022/ http://dx.doi.org/10.1016/S2666-6367(22)00643-1 |
| work_keys_str_mv | AT grahamrudianntamara favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT qayedmuna favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT leungkathryns favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT haightanne favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT parikhsuhag favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT watkinsbenk favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT horwitzedwin favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT chandrakasanshanmuganathan favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT schoettlermichellelong favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT bernardovaleria favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT harrisanora favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT landrykelly favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT yeemarianne favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease AT williamskirstenm favorableoutcomesofpediatrichematopoieticcelltransplantpatientsreceivingregencov2forprophylaxisagainstseverecovid19disease |